Urinary podocytes in primary focal segmental glomerulosclerosis.

Area of Science:

• Nephrology
• Pathology
• Urology

Background:

• Focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome.
• The exact pathogenesis of FSGS remains unclear, but emerging evidence points to podocyte disease.
• Investigating podocyte injury is crucial for understanding FSGS.

Purpose of the Study:

• To assess podocyte injury in patients with nephrotic syndrome.
• To quantify urinary podocytes as a marker of podocyte damage.
• To differentiate podocyte involvement in FSGS versus other nephrotic conditions.

Main Methods:

• Collected first morning urine samples from 71 nephrotic syndrome patients and 200 healthy controls.
• Utilized immunofluorescence labeling with anti-podocalyxin antibodies to detect urinary podocytes.
• Performed renal histology on 58 patients, categorizing them into minimal-change disease, FSGS, or membranous nephropathy.

Main Results:

• Patients with FSGS exhibited significantly higher urinary podocyte levels (median 1.3 cells/ml) compared to minimal-change disease (median 0 cells/ml) and membranous nephropathy (median 0 cells/ml).
• Urinary podocyte counts in FSGS patients ranged from 0-40.8 cells/ml, significantly exceeding those in minimal-change disease (0-6.9 cells/ml) and membranous nephropathy (0-1.4 cells/ml).
• Healthy controls showed minimal urinary podocytes (median 0 cells/ml, range 0-0.8 cells/ml).

Conclusions:

• Urinary podocyte excretion is markedly elevated in FSGS patients.
• These findings support the hypothesis that podocyte injury and loss are integral to FSGS pathogenesis.
• Urinary podocyte measurement offers a potential diagnostic or prognostic tool for FSGS.